We examined the effects of secobarbital and other sedative-hypnotic barbiturates on the neuronal death induced by exposure to excitatory amino acids or deprivation of oxygen or glucose in mouse cortical cell cultures. N-Methyl-D-aspartate (NMDA), a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate, and kainate toxicities were attenuated in a concentration-dependent fashion by high concentrations of secobarbital or thiopen tal. Antagonism of NMDA toxicity was not overcome by increasing NMDA concentration and not mimicked by ,),-aminobutyrate. Despite these antiexcitotoxic actions, secobarbital exacerbated the neuronal death induced by
deprivation of either glucose alone or oxygen and glucose together; death induced by oxygen deprivation alone was little affected. Thiopental and methohexital also in creased oxygen-glucose deprivation injury. A possible explanation for this injury potentiation was provided by the observation that secobarbital enhanced the cellular A TP depletion induced by combined oxygen-glucose de privation. Deleterious effects on ATP production may counterbalance the protective effects of barbiturates un der some conditions. Key Words: Adenosine triphos phate-G lu tama te-H ypogl ycemia-H ypoxia Ischemia.
animal models of focal ischemia (Smith et aI., 1974; Hoff et aI. , 1975; Michenfelder et aI., 1976; Levy and Brierley, 1979; Selman et aI. , 1981) , although no effect (Michenfelder and Milde, 1975; Gelb et aI. , 1986) and increased injury (Pulsinelli et aI., 1980; Selman et aI. , 1981 Selman et aI. , , 1982 have also been re ported (reviewed by Piatt and Schiff, 1984; Shapiro, 1985; Trauner, 1986) . Clinical studies have sug gested that barbiturates are not helpful in patients suffering cardiac arrest (Abramson et aI., 1986) or head trauma (Ward et aI., 1985) . Neurologic dys function after cardiopulmonary bypass was de creased by barbiturates in one study (N ussmeier et aI. , 1986) , but a more recent study reexamining this question under conditions of hypothermic bypass and arterial filtration was not able to demonstrate benefit (Zaidan et aI., 1991) .
Barbiturates antagonize the neuronal depolariza tion induced by excitatory amino acids (Richards and Smaje, 1976; Macdonald and Barker, 1979; Sawada and Yamamoto, 1985) . Since the neurotox icity of glutamate and related excitatory amino ac ids may be a factor in hypoxic-ischemic brain injury (Meldrum, 1985; Rothman and Olney, 1986; Choi, 1988) , some of the ability of barbiturates to protect against hypoxia-ischemia may be due to antago nism of excitatory amino acid neurotoxicity. Sup port for this possibility is provided by the finding that barbiturates can reduce the acute toxic swelling induced by N-methyl-D-aspartate (NMDA) or kain ate on chick retinal neurons (Olney et aI., 1986) . However, barbiturates have complex effects on cell metabolism, neuronal excitability, cerebral blood flow, and intracranial pressure. Perhaps some of these other parenchymal and systemic actions might mitigate against an antiexcitotoxic action, ac counting for the mixed results obtained with the use of barbiturates in cerebral hypoxia-ischemia in vivo.
As a step toward defining the direct parenchymal effects of barbiturate drugs in cerebral hypoxia ischemia, we sought to determine the effect of bar biturates on the cortical neuronal injury induced ei ther by application of glutamate agonists or by the deprivation of oxygen or glucose in the simplified model system of murine cortical cell culture (Choi et aI., 1987) . This work has appeared in abstract form Giffard et aI., 1990) .
MATERIALS AND METHODS
'Y-Aminobutyrate (GABA), tetrodotoxin (TTX), excit atory amino acids, and barbiturates (except methohexital) were obtained from Sigma (St. Louis, MO, U.S.A.). Methohexital was obtained from Eli Lilly (Indianapolis, IN, U.S.A.). o-2-Amino-5-phosphonovalerate (o-APV) was from Tocris Neuramin (Essex, England). Culture me dium was purchased from Gibco (Grand Island, NY, U.S.A.), and serum from Hyc10ne (Logan, UT, U.S.A.). All tested drugs were dissolved in aqueous solution.
Cultures
Dissociated murine cortical cultures containing both neurons and glia were prepared from fetal Swiss Webster mice as previously described . Some cultures were plated on preexisting glial cultures made from newborn mice, a modification that reduced culture variability (Rose et aI., 1993) . The cultures were plated in medium consisting of Eagle's Minimal Essential Medium (MEM; Earle's salts, supplied glutamine-free) supple mented with 10% heat-inactivated horse serum, 10% fetal bovine serum, 2 mM glutamine, and 21 mM glucose. Sub sequent maintenance was in the same medium without fetal serum. Cultures were kept at 37°C in a humidified incubator with a 5% carbon dioxide atmosphere and used after 14-20 days in vitro.
Injury protocols
For 5-min exposure to excitatory amino acids with or without barbiturates, cultures were transferred into a de fined salt solution with the following composition (mM): NaC1120, KCI 5.4, MgCl2 0.8, CaCl2 1.8, glucose 15, and Tris 25. After the 5-min exposure, drugs were washed out and the cultures were placed in MEM supplemented with J Cereb Blood Flow Metab, Vol. 13, No.5, 1993 glucose (total 21 mM) for 24 h. Twenty-four-hour expo sure to excitatory amino acids was carried out in MEM with 21 mM glucose.
Cultures were deprived of glucose by washing into a glucose-free solution with the following composition (mM): NaCI 116, KCl 5.4, MgS04 0.8, NaH2P04 1.0, NaHC03 26, and CaCl2 1.8. Glucose deprivation was ter minated by adding glucose back to the specified final con centration. Cultures were deprived of oxygen or both ox ygen and glucose by replacing the culture medium with an oxygen-depleted solution of the same composition, inside an anoxia chamber (oxygen <0.2%; Forma Scientific, Marietta, OH, U.S.A.). After exposure durations of sev eral hours used for isolated oxygen deprivation, the ex posure was terminated simply by returning the cultures to the normal culture incubator. Combined oxygen-glucose deprivation was terminated by washing the cultures back into oxygenated MEM containing 5.5 mM glucose. In the case of combined oxygen-glucose deprivation, barbitu rates were added during the period of oxygen glucose deprivation and washed out at the termination of the in sult period. Twenty-four hours after initiation of an exci totoxic or substrate deprivation insult, neuronal injury was assessed morphologically by phase-contrast micros copy and quantitated by assay of lactate dehydrogenase (LDH) released into the bathing medium (Koh and Choi, 1987b) . The small amount of LDH present in sister cul tures exposed to sham wash was subtracted from all val ues to yield the specific injury signal, except as specifi cally noted below. Barbiturate drugs did not interfere with the LDH assay itself.
ATP content
ATP content was determined using a slightly modified version of the luciferin-luciferase assay described by Lust et al. (1981) . At the end of the insult period, the medium was removed and the cells solubilized immedi ately in ice-cold 0.1 M NaOH, 1 mM ethylenediamine tetraacetic acid at 0.3 ml/well. After deproteinizing with perchloric acid and subsequent precipitation of perchlo rate, freshly prepared luciferin-luciferase was added, and chemiluminescence was detected in a Packard scintilla tion counter (Meriden, CT, U.S.A.) in single-photon mode. ATP standards were processed with unknowns and run with each determination.
RESULTS
As previously described, cultures exposed to 500 fLM NMDA for 5 min developed immediate swelling of neuronal cell bodies; over the next 24 h, there was widespread neuronal degeneration without glial degeneration (Choi et aI., 1987) . Addition of 100 fLM to 3 mM secobarbital to the NMDA exposure solu tion produced a concentration-dependent reduction in acute neuronal swelling, as well as a reduction in neuronal cell loss and LDH efflux to the bathing medium by the next day (Figs. 1 and 2A). Addition of 3 mM secobarbital reduced the neuronal loss pro duced by NMDA to 38 ± 12% of control (mean ± SD, 16 separate experiments, each using three to four cultures). If the protection produced by 3 mM secobarbital is used as the maximal effect, the pro tective IC50 for secobarbital was 430 ± 160 /-lM (mean ± SD for four experiments). A similar reduc tion in NMDA neurotoxicity was observed with ad- dition of the other sedative hypnotic barbiturates, thiopental ( Fig. 2B ) and pentobarbital. Pentobar bital (3 mM) reduced NMDA toxicity to 51 ± 8% of control (mean ± SD, four experiments). Neuronal damage induced by exposure to 500 /-lM glutamate for 5 min was also reduced by 3 mM secobarbital to 52 ± 18% (mean ± SD, five experiments). One possible mechanism of barbiturate protec tion would be augmentation of GABA inhibition, leading to reduced excitatory activity. However, neither suppression of action potentials with 3 /-lM TTX nor addition of 1 mM GABA to the bath re produced the protective effects of secobarbital on NMDA neurotoxicity (Fig. 3) . Previously reported experiments showed that little of this 1 mM GABA is removed by cellular uptake over 10 min and that (SECO) is not mimicked by -y-aminobutyrate (GABA) or tetrodotoxin (TTX). Cultures were exposed to 500 iJ-M N-methyl-o aspartate (NMDA) for 5 min alone or in the presence of 3 mM secobarbital, 1 mM GABA, or 3 iJ-M TTX; lactate dehydroge nase (LDH) in the bathing medium was measured 24 h after the excitotoxic exposure (see Fig. 2 this exposure is no itself toxic (Koh and Choi, 1987a) . Muscimol at 1 mM also showed little pro tective effect against brief intense exposure to NMDA (Monyer et aI. , 1990) . To establish whether secobarbital was acting as a competitive or noncompetitive antagonist, we de termined the NMDA concentration-toxicity rela tionship in the presence or absence of 3 mM seco barbital. Secobarbital reduced the maximum injury produced by high concentrations ofNMDA (Fig. 4) , suggestive of noncompetitive antagonism. For com parison, the effect of D-APV, a known competitive antagonist (Watkins and Olverman, 1987) , is also shown. In addition to their protective action against rap idly triggered, NMDA receptor-mediated injury, secobarbital and thiopental also attenuated the slowly triggered excitotoxicity induced by 24-h ex posure to 10 IJ-M a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) or 100 IJ-M kainate (Fig. 5) .
The ability of secobarbital and other sedative hypnotic barbiturates to protect cortical neurons against excitotoxic injury suggested that they would also be protective against the neuronal injury in duced by deprivation of oxygen or glucose. In the past we have found such injury to be readily inhib ited by NMDA antagonists (Goldberg et aI., 1987 ; Barbiturates attenuate a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) or kainate neurotoxicity. A: Cultures were exposed to 10 iJ-M AMPA for 24 h, either alone or in the presence of the indicated barbiturate at 100 or 300 iJ-M. Lactate dehydrogenase (LDH) was measured at the end of the AMPA exposure (mean ± SD, n = 4 per condition; shown relative to LDH release produced by 24-h exposure to NMDA, = 100). 'Significantly different from control (AMPA alone) by analysis of variance and Student-Newman-Keuls test at p < 0.05. B: Same but with exposure to 100 iJ-M kainate for 24 h. Similar results to those in both panels were obtained in three additional experiments.
Monyer et aI., 1989; Kaku et aI. , 1991) and agents that diminish glutamate release (Goldberg et aI. , 1988; Monyer et aI., 1992) . As previously reported, a 6-to lO-h period of glucose deprivation induced widespread neuronal injury by the next day (Monyer et aI., 1989) . Sur prisingly, the addition of 0.5 mM secobarbital en hanced this injury, so that widespread neuronal loss occurred after 4-5 h of glucose deprivation (Fig. 6) . This exposure to secobarbital alone was not neuro toxic in the presence of normal (5.5 mM) glucose. Rather, an interaction between secobarbital con centration and level of glucose deprivation could be demonstrated, with higher glucose concentrations permitting tolerance of higher secobarbital concen trations (Fig. 6) .
Also, unlike other NMDA antagonists, secobar bital had little effect on neuronal survival after a pure hypoxic insult (Fig. 7) . Secobarbital as well as the hypnotic barbiturates thiopental and methohex ital all increased neuronal death when added to cul tures deprived of both glucose and oxygen (Fig. 8) at concentrations that did not produce neurotoxic ity in the presence of 5.5 mM glucose and nor moxia. One plausible explanation for the failure of bar biturates to protect cortical neurons against damage by oxygen or glucose deprivation might be that these compounds exacerbate the cellular energy de pletion induced by these insults. Barbiturates are known to inhibit oxidative phosphorylation (Brody and Bain, 1954; Aldridge and Parker, 1960; Chance and Hollunger, 1963) and thus might promote more rapid depletion of cellular ATP stores.
To test this hypothesis, we measured the ATP content of the cultures at the end of the maximal insult that did not produce lysis at the end of the exposure period (Table 1) . For glucose deprivation this was 3-4 h, for combined oxygen glucose depri vation 43-45 min; both insults produced no or only modest injury at 24 h. For both glucose deprivation and combined oxygen-glucose deprivation, these durations of insult resulted in a nearly 50% decrease in ATP. When the same insults were carried out in the presence of 300 J.LM secobarbital, culture ATP levels were further reduced by another -30%. ATP levels were not significantly reduced in the pres ence of secobarbital after 7 h of pure hypoxia, an insult duration that did not produce early cell lysis or delayed injury. Control studies in astrocyte cul tures showed little change in A TP content after in sults of these durations (data not shown).
DISCUSSION
Consistent with the work of Olney et aI. (1986) in the chick retina, we observed here that secobarbital and other sedative-hypnotic barbiturates, chosen because they are currently used clinically as anes the tics , could protect cultured cortical neurons against excitotoxic damage induced by exposure to glutamate agonists. Most likely, these antiexcito toxic effects reflect largely the known ability of bar biturates to reduce current through AMPA/kainate receptor-activated channels as well as NMDA re ceptor-activated channels (Richards and Smaje, 1976; Macdonald and Barker, 1979; Sawada and Yamamoto, 1985) . Teichberg and co-workers (1984) found that barbiturate inhibition of kainate-evoked Na + efflux was noncompetItlve, with efflux in duced by kainate or quisqualate affected primarily by barbiturates. Excitotoxicity induced by AMPA was most readily inhibited by the barbiturates tested in the current study.
Barbiturates are known to have many effects on excitable cells beyond effects on glutamate recep tors, including blockade of voltage-gated calcium currents and inhibition of neurotransmitter release (Heyer and MacDonald, 1982; Werz and MacDon ald, 1985) , as well as augmentation of GAB A inhi bition (MacIver et aI., 1991) . At high concentra tions, barbiturates directly increase CI-conduc tance (MacDonald et aI., 1988) and block axonal Na + and K + conductances (Blaustein, 1968) . In deed, electrophysiologic effects associated with high barbiturate concentrations have been proposed to be involved in producing anesthesia (Heyer and MacDonald, 1982) . Further study will be required to determine whether any of these other barbiturate actions contribute to the antiexcitotoxic or injury potentiating effects observed here. The inability of GABA to mimic the neuroprotective effect of seco barbital against NMDA neurotoxicity argues against potentiation of CI-current as the main mechanism of barbiturate antiexcitotoxic action.
The major finding of the present study, however, is that despite its antiexcitotoxic action, secobar bital as well as other hypnotic barbiturates did not protect neurons against oxygen and/or glucose de privation. In fact, these drugs worsened the neuro nal death induced by either combined oxygen glucose deprivation or glucose deprivation alone. If the antiexcitotoxic action of secobarbital indeed re flects glutamate receptor antagonism, this striking discrepancy would represent the first example we have encountered in our system where an NMDA antagonist drug fails to reduce neuronal death after oxygen or glucose deprivation.
Such failures are not uncommon in animal models of ischemia, but the range of possible explanations An important topic for future study will be the nature of these adverse cellular actions. The de pressant effect of barbiturates on culture ATP lev els after combined oxygen-glucose deprivation or simple glucose deprivation provides one attractive possible explanation. As discussed above, barbitu rates can inhibit oxidative phosphorylation. Despite other presumably favorable effects on metabolic rate, Oberpichler et al. (1990) observed that meth ohexital failed to ameliorate the loss of ATP in chick cerebral cultures exposed to cyanide, and Duffy et al. (1972) found no significant effect of pen tobarbital on ATP levels in mouse brains exposed to hypoxia. Furthermore, Dagani and Erecinska (1987) observed that amy tal intensified A TP deple tion in glucose-deprived synaptosomes.
Our observation that secobarbital induced neuro nal injury only at lower glucose concentrations is also consistent with the idea that barbiturates may exacerbate cellular ATP depletion. Besides inhibi tion of oxidative phosphorylation, barbiturates may also inhibit hexokinase activity, leading to de creased glycolysis (Krieglstein et al., 1981; Okazaki et al. , 1991) .
We acknowledge that it is a long transition from cell culture to the intact nervous system and that many factors besides direct parenchymal actions may contribute to outcome in vivo, including changes in cerebral blood flow, temperature, and intracranial pressure. However, in summary, the present data raise the interesting hypothesis that secobarbital and other hypnotic barbiturates may have a direct injury-potentiating effect on the isch emic brain, capable of negating some of their ben eficial effects, including reduction of excitotoxicity. This injury-potentiating effect may contribute to the mixed track record that barbiturates have earned as neuroprotectant drugs in animal models and in the clinic. The high barbiturate concentrations used here are similar to concentrations achieved in some prior animal and human studies. Animal plasma lev els as high as 380 f.LM (Hoff et al., 1975 ) and brain levels as high as 200 f.LM (Krieglstein et al., 1981) have been reported. In human trials with thiopental, serum concentrations of 60--200 f.LM have been doc umented (Shapiro, 1985) .
Greater understanding of which features of barbiturate action are helpful, and which are harmful, in the setting of hypoxia-ischemia may aid the se lection of barbiturate drugs for specific clinical uses and promote the development of new barbiturate drugs with more favorable profiles.
